The independent assessment of distinct PLA2 subtypes, including activity and regional distribution, is probably the key to understanding the discrepancies of the enzymatic activity in Alzheimer’s disease (AD) and BD brain. This evidence concerns the gene PLA2G6 and Alzheimer disease.